OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.
| Revenue (TTM) | $581.12M |
| Gross Profit (TTM) | $86.68M |
| EBITDA | $-112.49M |
| Operating Margin | -41.10% |
| Return on Equity | -16.90% |
| Return on Assets | -6.36% |
| Revenue/Share (TTM) | $0.75 |
| Book Value | $1.67 |
| Price-to-Book | 0.69 |
| Price-to-Sales (TTM) | 1.44 |
| EV/Revenue | 1.524 |
| EV/EBITDA | 19.94 |
| Quarterly Earnings Growth (YoY) | -12.60% |
| Quarterly Revenue Growth (YoY) | -17.20% |
| Shares Outstanding | $755.09M |
| Float | $332.32M |
| % Insiders | 49.60% |
| % Institutions | 27.08% |
Volatility is currently expanding